Wagner M, Kulli C, Friess H, Seiler C A, Büchler M W
Klinik für Viszerale und Transplantationschirurgie, Universität Bern, Inselspital.
Swiss Surg. 2000;6(5):264-70. doi: 10.1024/1023-9332.6.5.264.
Pancreatic cancer is the third leading neoplasm of the gastrointestinal system and has a dismal prognosis. The majority of patients are no more suitable for resection at time of diagnosis due to early development of distant metastases or major infiltration of adjacent structures. However, due to the resistance of pancreatic cancer against radiation and chemotherapy, radical resection represents the only therapy with a potential for cure. For the surgical treatment of pancreatic head cancer, the classical Whipple operation is still the standard procedure but during the last two decades, pylorus-preserving pancreatoduodenectomy has been evolved as a more conservative procedure in order to omit the consequences of partial gastrectomy. For cancer of the pancreatic body and tail, distal pancreatectomy or total pancreatectomy represent the current standard treatment. More radical methods like regional pancreatectomy and resection with extended lymph node dissection have failed so far to demonstrate any improvements in long-term survival compared to the standard types of resection. To further improve the treatment of pancreatic cancer, prospectively randomized trials are needed to compare extended surgical procedures with the standard types of resection and the efficiency of various adjuvant therapies.
胰腺癌是消化系统第三大常见肿瘤,预后很差。由于大多数患者在诊断时已出现远处转移或邻近结构的严重浸润,不再适合手术切除。然而,由于胰腺癌对放疗和化疗具有抗性,根治性切除是唯一有可能治愈的治疗方法。对于胰头癌的外科治疗,经典的惠普尔手术仍然是标准术式,但在过去二十年中,保留幽门的胰十二指肠切除术已发展成为一种更为保守的术式,以避免部分胃切除的后果。对于胰体尾癌,远端胰腺切除术或全胰腺切除术是目前的标准治疗方法。与标准切除术相比,诸如区域性胰腺切除术和扩大淋巴结清扫术等更为激进的方法目前尚未显示出对长期生存有任何改善。为了进一步改善胰腺癌的治疗,需要进行前瞻性随机试验,以比较扩大手术与标准切除术以及各种辅助治疗的效果。